Incidence of ischemic colitis in clinical trials and post-marketing surveillance amongst patients using alosetrom after blinded adjudication

被引：0
|
作者：
Chey, WD
Chang, L
Harris, L
Olden, K
Surawicz, C
Schoenfeld, P
机构：
来源：
GASTROENTEROLOGY | 2005年 / 128卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A465 / A465
页数：1
相关论文
共 50 条
  • [1] Incidence of ischemic colitis and serious complications of constipation among patients using alosetron: Systematic review of clinical trials and post-marketing surveillance data
    Chang, Lin
    Chey, William D.
    Harris, Lucinda
    Olden, Kevin
    Surawicz, Christina
    Schoenfeld, Philip
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (05): : 1069 - 1079
  • [2] CLINICAL-TRIALS IN POST-MARKETING SURVEILLANCE OF DRUGS
    BELL, RL
    SMITH, EO
    CONTROLLED CLINICAL TRIALS, 1982, 3 (01): : 61 - 68
  • [3] Transdermal buprenorphine in clinical practice - a post-marketing surveillance study in 13179 patients
    Griessinger, N
    Sittl, R
    Likar, R
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (08) : 1147 - 1156
  • [4] Safety and effectiveness of tofacitinib in Korean adult patients with ulcerative colitis: post-marketing surveillance study
    Yoon, Hyuk
    Ye, Byong Duk
    Kang, Sang-Bum
    Lee, Kang-Moon
    Choi, Chang Hwan
    Jo, Joo-young
    Woo, Juwon
    Cheon, Jae Hee
    BMC GASTROENTEROLOGY, 2024, 24 (01)
  • [5] PHASE-IV CLINICAL-TRIALS WITH CEFTIZOXIME (EPOSERIN) IN 3201 PATIENTS IN ITALY - A POST-MARKETING SURVEILLANCE REPORT
    GAROTTA, F
    UMILE, A
    PAMPARANA, F
    MONTORO, C
    MEINARDI, G
    CLINICAL TRIALS JOURNAL, 1989, 26 (03) : 201 - 215
  • [6] Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: A final report of effectiveness and safety data
    Matsuoka, K.
    Motoya, S.
    Yamamoto, T.
    Matsuura, M.
    Fujii, T.
    Shinzaki, S.
    Mikami, Y.
    Arai, S.
    Oshima, J.
    Endo, Y.
    Yuasa, H.
    Hoshi, M.
    Sato, K.
    Hisamatsu, T.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1407 - I1409
  • [7] An update on the safety and tolerability of pimecrolimus cream 1%: Evidence from clinical trials and post-marketing surveillance
    Langley, Richard G. B.
    Luger, Thomas A.
    Cork, Michael J.
    Schneider, Dirk
    Paul, Carle
    DERMATOLOGY, 2007, 215 : 27 - 44
  • [8] SURVEY OF THE KNOWLEDGE AND ATTITUDES OF MEDICAL DOCTORS AND PATIENTS FOR PARTICIPATION IN POST-MARKETING CLINICAL TRIALS
    Atanasov, V.
    Getov, I.
    PHARMACIA, 2016, 63 (02) : 30 - 34
  • [9] Safety and Effectiveness of Apixaban in Japanese Patients With Venous Thromboembolism in Clinical Practice ― A Post-Marketing Surveillance ―
    Yamada, Norikazu
    Mo, Makoto
    Ohsawa, Ako
    Sato, Motoki
    Umeyama, Michiaki
    Shima, Daisuke
    Nakamura, Mashio
    CIRCULATION JOURNAL, 2024, 88 (02) : 263
  • [10] Safety and Effectiveness of Apixaban in Japanese Patients With Venous Thromboembolism in Clinical Practice - A Post-Marketing Surveillance -
    Yamada, Norikazu
    Mo, Makoto
    Ohsawa, Ako
    Sato, Motoki
    Umeyama, Michiaki
    Shima, Daisuke
    Nakamura, Mashio
    CIRCULATION JOURNAL, 2021, 85 (12) : 2201 - +
12345